Trexan 2,5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

trexan 2,5 mg

orion corporation, fínsko - metotrexát - 44 - cytostatica

Trexan 10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

trexan 10 mg

orion corporation, fínsko - metotrexát - 44 - cytostatica

Immunoprin 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

immunoprin 100 mg

sandoz pharmaceuticals d.d., slovinsko - azatioprín - 59 - immunopraeparata

Jayempi Európska únia - slovenčina - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - odmietnutie štepu - imunosupresíva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Ibrance Európska únia - slovenčina - EMA (European Medicines Agency)

ibrance

pfizer europe ma eeig  - palbociclib - neoplazmy prsníkov - antineoplastické činidlá - ibrance je indikovaný na liečbu hormonálne receptory (hr), pozitívnu, ľudskej pokožky growth factor receptor 2 (her2) negatívne lokálne pokročilého alebo metastatického karcinómu prsníka:v kombinácii s inhibítor aromatázy;v kombinácii s fulvestrant u žien, ktoré dostali pred žliaz s vnútornou sekréciou, terapia. v pre - alebo perimenopauzálnych žien, endokrinný terapie by mali byť kombinované s luteinizačného hormónu uvoľňujúci hormón (lhrh) agonist.

Solymbic Európska únia - slovenčina - EMA (European Medicines Agency)

solymbic

amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - imunosupresíva - pozrite si časť 4. 1 v súhrne charakteristických vlastností výrobku v informačnom dokumente o výrobku.

Cyltezo Európska únia - slovenčina - EMA (European Medicines Agency)

cyltezo

boehringer ingelheim international gmbh - adalimumab - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - imunosupresíva - pozrite si časť 4. 1 v súhrne charakteristických vlastností výrobku v informačnom dokumente o výrobku.

Imuran 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imuran 50 mg

aspen pharma trading limited, Írsko - azatioprín - 59 - immunopraeparata

Tardyferon-Fol Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tardyferon-fol

pierre fabre medicament , francúzsko - síran železnatý - 12 - antianaemica

Imuran 25 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imuran 25 mg

aspen pharma trading limited, Írsko - azatioprín - 59 - immunopraeparata